Shaanxi Panlong Pharmaceutical News

Panlong Pharmaceutical (002864): Proposed appointment of new executives may be expected to bring new breakthroughs

Feb 21 00:00

Panlong Pharmaceutical (002864): Short-term performance pressure, plans to buy back shares, demonstrating long-term confidence

Nov 12, 2023 00:00

Panlong Pharmaceutical (002864): Panlong Seven, the core product of the leading brand of traditional Chinese medicine for rheumatism and bone injury in China, has great potential

Nov 7, 2023 00:00

Panlong Pharmaceutical (002864): Qin Pharmaceutical Treasure Builds Leading Brand of Rheumatology and Bone Injury Drugs

Oct 14, 2023 00:00

Panlong Pharmaceutical (002864) IPO Research: A Rising Star in the Traditional Chinese Medicine Industry Leading Brand for Rheumatology and Bone Injury

興業證券Nov 13, 2017 00:00

Panlong Pharmaceutical Company (002864) Inquiry report on New shares

華鑫證券Oct 26, 2017 00:00